APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crizotinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Crizotinib Drugs Market Outlook and Growth Opportunities 2026

23 December 2025199 pages

Choose your research edition.

Industry ResearchCrizotinib Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Crizotinib Drugs Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Crizotinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crizotinib Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Crizotinib Drugs Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Crizotinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Crizotinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Crizotinib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Crizotinib Drugs market include Wanbang Biopharmaceuticals, Pfizer, Genvio Pharma, Everest Pharmaceuticals, Drug International, Beacom and Azista, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Crizotinib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Crizotinib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Crizotinib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Crizotinib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Crizotinib Drugs Segment by Company

Wanbang Biopharmaceuticals

Pfizer

Genvio Pharma

Everest Pharmaceuticals

Drug International

Beacom

Azista

Crizotinib Drugs Segment by Type

Capsules

Oral Pellets

Crizotinib Drugs Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Crizotinib Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Crizotinib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Crizotinib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Crizotinib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Crizotinib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Crizotinib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Crizotinib Drugs industry.

Chapter 3: Detailed analysis of Crizotinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Crizotinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Crizotinib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Crizotinib Drugs Industry Trends Table 2. Crizotinib Drugs Industry Drivers Table 3. Crizotinib Drugs Industry Opportunities and Challenges Table 4. Crizotinib Drugs Industry Restraints Table 5. Global Crizotinib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Crizotinib Drugs Revenue Share by Company (2021-2026) Table 7. Global Crizotinib Drugs Sales Volume by Company (k units) & (2021-2026) Table 8. Global Crizotinib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Crizotinib Drugs Average Price (US$/unit) of Company (2021-2026) Table 10. Global Crizotinib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Crizotinib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Crizotinib Drugs Company, Product Type & Application Table 13. Global Crizotinib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Crizotinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Capsules Table 18. Significant Companies of Oral Pellets Table 19. Global Crizotinib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Crizotinib Drugs Sales Volume by Type (2021-2026) & (k units) Table 21. Global Crizotinib Drugs Sales Volume by Type (2027-2032) & (k units) Table 22. Global Crizotinib Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Crizotinib Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Crizotinib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Crizotinib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Crizotinib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Crizotinib Drugs Sales Value Share by Type (2021-2026) Table 28. Global Crizotinib Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Crizotinib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Crizotinib Drugs Sales Volume by Application (2021-2026) & (k units) Table 34. Global Crizotinib Drugs Sales Volume by Application (2027-2032) & (k units) Table 35. Global Crizotinib Drugs Sales Volume Share by Application (2021-2026) Table 36. Global Crizotinib Drugs Sales Volume Share by Application (2027-2032) Table 37. Global Crizotinib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Crizotinib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Crizotinib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Crizotinib Drugs Sales Value Share by Application (2021-2026) Table 41. Global Crizotinib Drugs Sales Value Share by Application (2027-2032) Table 42. Global Crizotinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Crizotinib Drugs Sales by Region (2021-2026) & (k units) Table 44. Global Crizotinib Drugs Sales Market Share by Region (2021-2026) Table 45. Global Crizotinib Drugs Sales by Region (2027-2032) & (k units) Table 46. Global Crizotinib Drugs Sales Market Share by Region (2027-2032) Table 47. Global Crizotinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Crizotinib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Crizotinib Drugs Sales Value Share by Region (2021-2026) Table 50. Global Crizotinib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Crizotinib Drugs Sales Value Share by Region (2027-2032) Table 52. Global Crizotinib Drugs Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global Crizotinib Drugs Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global Crizotinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Crizotinib Drugs Sales by Country (2021-2026) & (k units) Table 57. Global Crizotinib Drugs Sales Market Share by Country (2021-2026) Table 58. Global Crizotinib Drugs Sales by Country (2027-2032) & (k units) Table 59. Global Crizotinib Drugs Sales Market Share by Country (2027-2032) Table 60. Global Crizotinib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Crizotinib Drugs Sales Value Market Share by Country (2021-2026) Table 62. Global Crizotinib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Crizotinib Drugs Sales Value Market Share by Country (2027-2032) Table 64. Wanbang Biopharmaceuticals Company Information Table 65. Wanbang Biopharmaceuticals Business Overview Table 66. Wanbang Biopharmaceuticals Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Wanbang Biopharmaceuticals Crizotinib Drugs Product Portfolio Table 68. Wanbang Biopharmaceuticals Recent Development Table 69. Pfizer Company Information Table 70. Pfizer Business Overview Table 71. Pfizer Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Pfizer Crizotinib Drugs Product Portfolio Table 73. Pfizer Recent Development Table 74. Genvio Pharma Company Information Table 75. Genvio Pharma Business Overview Table 76. Genvio Pharma Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Genvio Pharma Crizotinib Drugs Product Portfolio Table 78. Genvio Pharma Recent Development Table 79. Everest Pharmaceuticals Company Information Table 80. Everest Pharmaceuticals Business Overview Table 81. Everest Pharmaceuticals Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Everest Pharmaceuticals Crizotinib Drugs Product Portfolio Table 83. Everest Pharmaceuticals Recent Development Table 84. Drug International Company Information Table 85. Drug International Business Overview Table 86. Drug International Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Drug International Crizotinib Drugs Product Portfolio Table 88. Drug International Recent Development Table 89. Beacom Company Information Table 90. Beacom Business Overview Table 91. Beacom Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Beacom Crizotinib Drugs Product Portfolio Table 93. Beacom Recent Development Table 94. Azista Company Information Table 95. Azista Business Overview Table 96. Azista Crizotinib Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Azista Crizotinib Drugs Product Portfolio Table 98. Azista Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Crizotinib Drugs Distributors List Table 102. Crizotinib Drugs Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Crizotinib Drugs Product Image Figure 2. Global Crizotinib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Crizotinib Drugs Sales (2021-2032) & (k units) Figure 5. Global Crizotinib Drugs Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Crizotinib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Capsules Image Figure 10. Oral Pellets Image Figure 11. Global Crizotinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Crizotinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Crizotinib Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Crizotinib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Crizotinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Crizotinib Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Crizotinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Crizotinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Crizotinib Drugs Sales Volume Share by Application (2021-2032) Figure 23. Global Crizotinib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Crizotinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Crizotinib Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Crizotinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global Crizotinib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Crizotinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Crizotinib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. North America Crizotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Crizotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Crizotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. South America Crizotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Crizotinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Crizotinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Crizotinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Crizotinib Drugs Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Crizotinib Drugs Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Capsules
  • Oral Pellets
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Wanbang Biopharmaceuticals
  • Pfizer
  • Genvio Pharma
  • Everest Pharmaceuticals
  • Drug International
  • Beacom
  • Azista

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Crizotinib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Crizotinib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Crizotinib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Crizotinib Drugs Market Dynamics
  1. 2.1 Crizotinib Drugs Industry Trends
  2. 2.2 Crizotinib Drugs Industry Drivers
  3. 2.3 Crizotinib Drugs Industry Opportunities and Challenges
  4. 2.4 Crizotinib Drugs Industry Restraints
3 Crizotinib Drugs Market by Company
  1. 3.1 Global Crizotinib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Crizotinib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Crizotinib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Crizotinib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Crizotinib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Crizotinib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Crizotinib Drugs Company Product Type and Application
  8. 3.8 Global Crizotinib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Crizotinib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Crizotinib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Crizotinib Drugs Market by Type
  1. 4.1 Crizotinib Drugs Type Introduction
  2. 4.1.1 Capsules
  3. 4.1.2 Oral Pellets
  4. 4.2 Global Crizotinib Drugs Sales Volume by Type
  5. 4.2.1 Global Crizotinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Crizotinib Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Crizotinib Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Crizotinib Drugs Sales Value by Type
  9. 4.3.1 Global Crizotinib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Crizotinib Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Crizotinib Drugs Sales Value Share by Type (2021-2032)
5 Crizotinib Drugs Market by Application
  1. 5.1 Crizotinib Drugs Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Crizotinib Drugs Sales Volume by Application
  6. 5.2.1 Global Crizotinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Crizotinib Drugs Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Crizotinib Drugs Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Crizotinib Drugs Sales Value by Application
  10. 5.3.1 Global Crizotinib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Crizotinib Drugs Sales Value by Application (2021-2032)
  12. 5.3.3 Global Crizotinib Drugs Sales Value Share by Application (2021-2032)
6 Crizotinib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Crizotinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Crizotinib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Crizotinib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Crizotinib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Crizotinib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Crizotinib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Crizotinib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Crizotinib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Crizotinib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Crizotinib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Crizotinib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Crizotinib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Crizotinib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Crizotinib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Crizotinib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Crizotinib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Crizotinib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Crizotinib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Crizotinib Drugs Sales Value Share by Country, 2025 VS 2032
7 Crizotinib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Crizotinib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Crizotinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Crizotinib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Crizotinib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Crizotinib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Crizotinib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Crizotinib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Crizotinib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Crizotinib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Crizotinib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Crizotinib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wanbang Biopharmaceuticals
  2. 8.1.1 Wanbang Biopharmaceuticals Company Information
  3. 8.1.2 Wanbang Biopharmaceuticals Business Overview
  4. 8.1.3 Wanbang Biopharmaceuticals Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wanbang Biopharmaceuticals Crizotinib Drugs Product Portfolio
  6. 8.1.5 Wanbang Biopharmaceuticals Recent Developments
  7. 8.2 Pfizer
  8. 8.2.1 Pfizer Company Information
  9. 8.2.2 Pfizer Business Overview
  10. 8.2.3 Pfizer Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Pfizer Crizotinib Drugs Product Portfolio
  12. 8.2.5 Pfizer Recent Developments
  13. 8.3 Genvio Pharma
  14. 8.3.1 Genvio Pharma Company Information
  15. 8.3.2 Genvio Pharma Business Overview
  16. 8.3.3 Genvio Pharma Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Genvio Pharma Crizotinib Drugs Product Portfolio
  18. 8.3.5 Genvio Pharma Recent Developments
  19. 8.4 Everest Pharmaceuticals
  20. 8.4.1 Everest Pharmaceuticals Company Information
  21. 8.4.2 Everest Pharmaceuticals Business Overview
  22. 8.4.3 Everest Pharmaceuticals Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Everest Pharmaceuticals Crizotinib Drugs Product Portfolio
  24. 8.4.5 Everest Pharmaceuticals Recent Developments
  25. 8.5 Drug International
  26. 8.5.1 Drug International Company Information
  27. 8.5.2 Drug International Business Overview
  28. 8.5.3 Drug International Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Drug International Crizotinib Drugs Product Portfolio
  30. 8.5.5 Drug International Recent Developments
  31. 8.6 Beacom
  32. 8.6.1 Beacom Company Information
  33. 8.6.2 Beacom Business Overview
  34. 8.6.3 Beacom Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Beacom Crizotinib Drugs Product Portfolio
  36. 8.6.5 Beacom Recent Developments
  37. 8.7 Azista
  38. 8.7.1 Azista Company Information
  39. 8.7.2 Azista Business Overview
  40. 8.7.3 Azista Crizotinib Drugs Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Azista Crizotinib Drugs Product Portfolio
  42. 8.7.5 Azista Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Crizotinib Drugs Value Chain Analysis
  2. 9.1.1 Crizotinib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Crizotinib Drugs Sales Mode & Process
  6. 9.2 Crizotinib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Crizotinib Drugs Distributors
  9. 9.2.3 Crizotinib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst